Cargando…

Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress

BACKGROUND: Sulindac is an FDA-approved non-steroidal anti-inflammatory drug (NSAID) that affects prostaglandin production by inhibiting cyclooxygenases (COX) 1 and 2. Sulindac has also been of interest for more than decade as a chemopreventive for adenomatous colorectal polyps and colon cancer. PRI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marchetti, Maria, Resnick, Lionel, Gamliel, Edna, Kesaraju, Shailaja, Weissbach, Herbert, Binninger, David
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686156/ https://www.ncbi.nlm.nih.gov/pubmed/19503837 http://dx.doi.org/10.1371/journal.pone.0005804

Ejemplares similares

Combination of Sulindac and Dichloroacetate Kills Cancer Cells via Oxidative Damage
por: Ayyanathan, Kasirajan, et al.
Publicado: (2012)

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development
por: Davis, Jennifer S., et al.
Publicado: (2020)

Sulindac for stroke treatment: neuroprotective mechanism and therapy
por: Modi, Jigar Pravinchandra, et al.
Publicado: (2014)

Amine Containing Analogs of Sulindac for Cancer Prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Oxazole and thiazole analogs of sulindac for cancer prevention
por: Mathew, Bini, et al.
Publicado: (2018)

Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics
por: CHENG, KA-WING, et al.
Publicado: (2013)

Sulindac Prevents Esophageal Adenocarcinomas Induced by Gastroduodenal Reflux in Rats
por: Kim, Sung Wook, et al.
Publicado: (2007)

A Desmoid Tumor Responding to Systemic Therapy With Tamoxifen and Sulindac
por: Choudhury, Hasan, et al.
Publicado: (2023)

Sulindac metabolites inhibit epidermal growth factor receptor activation and expression
por: Pangburn, Heather A, et al.
Publicado: (2005)

Sulindac activates NF-κB signaling in colon cancer cells
por: Mladenova, Dessislava, et al.
Publicado: (2013)

Analysis of the Dissolution Mechanism of Drugs into Polymers: The Case of the PVP/Sulindac System
por: Latreche, Mansour, et al.
Publicado: (2023)

Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits
por: Verheul, H M W, et al.
Publicado: (1999)

Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice
por: Bi, Xiuli, et al.
Publicado: (2013)

Synergistic cytotoxic effect of sulindac and pyrrolidine dithiocarbamate against ovarian cancer cells
por: JAKUBOWSKA-MUĆKA, ANNA, et al.
Publicado: (2012)

Induction of Apoptosis by Sulindac in Azoxymethane‐induced Possible Colonic Premalignant Lesions in Rats
por: Kuno, Toshiya, et al.
Publicado: (2002)

Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers
por: Tang, Yong-Jun, et al.
Publicado: (2017)

Radioprotective Potential of Sulindac Sulfide to Prevent DNA Damage Due to Ionizing Radiation
por: Torabizadeh, Seyedeh Atekeh, et al.
Publicado: (2019)

The effect of sulindac on redox homeostasis and apoptosis-related proteins in melanotic and amelanotic cells
por: Miliński, Maciej, et al.
Publicado: (2023)

Effect of Sulindac Sulfide on Metallohydrolases in the Human Colon Cancer Cell Line HT-29
por: Guillen-Ahlers, Hector, et al.
Publicado: (2011)

Sulindac Derivatives That Activate the Peroxisome Proliferator-activated Receptor γ but Lack Cyclooxygenase Inhibition
por: Felts, Andrew S., et al.
Publicado: (2008)

Topical phospho-sulindac (OXT-328) is effective in the treatment of non-melanoma skin cancer
por: CHENG, KA WING, et al.
Publicado: (2012)

The efficacy and safety of sulindac for colorectal polyps: A protocol for systematic review and meta-analysis
por: Long, Qing, et al.
Publicado: (2020)

Modification of the Release of Poorly Soluble Sulindac with the APTES-Modified SBA-15 Mesoporous Silica
por: Dadej, Adrianna, et al.
Publicado: (2021)

Sulindac selectively induces autophagic apoptosis of GABAergic neurons and alters motor behaviour in zebrafish
por: Sun, Wenwei, et al.
Publicado: (2023)

Cyclooxygenase-1-Selective Inhibitors Based on the (E)-2′-Des-methyl-sulindac Sulfide Scaffold
por: Liedtke, Andy J., et al.
Publicado: (2012)

Phospho-sulindac inhibits pancreatic cancer growth: NFATc1 as a drug resistance candidate
por: MURRAY, ONIKA T., et al.
Publicado: (2013)

Nutrient Availability Alters the Effect of Autophagy on Sulindac Sulfide-Induced Colon Cancer Cell Apoptosis
por: Chiou, Shiun-Kwei, et al.
Publicado: (2012)

Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21
por: Zhou, Xue, et al.
Publicado: (2015)

Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors
por: Li, Xi, et al.
Publicado: (2015)

Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas
por: Chang, Wen-Chi L, et al.
Publicado: (2018)

Molecular dynamics simulation and docking analysis of NF-κB protein binding with sulindac acid
por: Ahmad, Shaban, et al.
Publicado: (2022)

Sulindac acetohydrazide derivative attenuates against cisplatin induced organ damage by modulation of antioxidant and inflammatory signaling pathways
por: Razak, Suhail, et al.
Publicado: (2022)

Sulindac inhibits tumor cell invasion by suppressing NF-κB mediated transcription of microRNAs
por: Li, Xiaobo, et al.
Publicado: (2012)

Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator
por: Yin, Tao, et al.
Publicado: (2016)

New use for an old drug: COX‐independent anti‐inflammatory effects of sulindac in models of cystic fibrosis
por: Rocca, Jérémy, et al.
Publicado: (2016)

Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion
por: Whitt, Jason D., et al.
Publicado: (2016)

Effect of Sulindac Binary System on In Vitro and In Vivo Release Profiles: An Assessment of Polymer Type and Its Ratio
por: Shazly, Gamal A.
Publicado: (2016)

Longitudinal analysis of colon crypt stem cell dynamics in sulindac treated Familial Adenomatous Polyposis patients
por: Ma, Huiying, et al.
Publicado: (2017)

Identification of the Effects of Aspirin and Sulindac Sulfide on the Inhibition of HMGA2-Mediated Oncogenic Capacities in Colorectal Cancer
por: Ekanem, Titus Ime, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pq3tssc25625n646kf7qealg7f